findmyKOL

Heinz-Josef Lenz, MD

Enriched profile

Professor of Medicine and Preventive Medicine; Deputy Director for Research Programs and Co-Leader, Gastrointestinal Cancers Program, USC Norris Comprehensive Cancer Center; J. Terrence Lanni Chair for Cancer Research, Division of Medical Oncology; Section Head of GI Oncology and Co-Director of the Colorectal Center, Keck School of Medicine of USC · USC Norris Comprehensive Cancer Center

ORCIDNPI
RegionLos Angeles, CA · WestSpecialtyMedical OncologyFocusColorectal Cancer Treatments and Studies+4
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Heinz-Josef Lenz is Professor of Medicine and Preventive Medicine; Deputy Director for Research Programs and Co-Leader, Gastrointestinal Cancers Program, USC Norris Comprehensive Cancer Center; J. Terrence Lanni Chair for Cancer Research, Division of Medical Oncology; Section Head of GI Oncology and Co-Director of the Colorectal Center, Keck School of Medicine of USC at USC Norris Comprehensive Cancer Center. OpenAlex indexes 1,849 publications with 57,638 citations (h-index 107); ClinicalTrials.gov lists 25 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Medical Oncology profiles in the findmyKOL directory.

Data verified 25 Aug 2026

Overview

Updated 27 Aug 2026

Heinz-Josef Lenz is Professor of Medicine and Preventive Medicine at USC Norris Comprehensive Cancer Center / Keck School of Medicine of USC. The public record shows 1,849 publications with 57,638 citations (h-index 107), centered on Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics. It also documents an investigator role on 23 registered clinical trials.

  • Most recent indexed publication: 2026 · Oncogene
  • Top research focus: Colorectal Cancer Treatments and Studies
  • 23 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Colorectal Cancer11 trialsRectal Neoplasms10 trialsGastroesophageal Cancer3 trialsStomach Neoplasms3 trialsColonic Neoplasms3 trialsBladder / Urothelial Cancer1 trialGallbladder Neoplasms1 trialBile Duct Neoplasms1 trialPancreatic Cancer1 trialLung Cancer (NSCLC/SCLC)1 trialIntestinal Neoplasms1 trialHepatobiliary Cancer1 trialLiver Neoplasms1 trialCOVID-191 trial

Research focus

OpenAlex concept fingerprint
Colorectal Cancer Treatments and StudiesGenetic factors in colorectal cancerCancer Genomics and DiagnosticsGastric Cancer Management and OutcomesCancer Treatment and Pharmacology

Drugs & molecules

across trials, industry payments and publications
Stivargageneric · RegorafenibClinical trials1Industry payments2Publications2Nexavargeneric · SorafenibClinical trials1Industry payments2Publications1BevacizumabClinical trials2Industry paymentsPublications15

Works with

trial sponsors and companies reporting payments
E.R. Squibb & Sons, L.L.C.Clinical trialsIndustry payments54Abbvie Inc.Clinical trialsIndustry payments15Merck Sharp & Dohme LLCClinical trialsIndustry payments10

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,849publications

Distinct works indexed by OpenAlex, matched via ORCID; 88 in PubMed.

57,638citations

Total citations across indexed works.

107h-index

Hirsch index (OpenAlex). i10-index 532.

Clinical & industry

trials, payments and federal funding
25clinical trials

Investigator role on registered studies.

View trials
20companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 25 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Genitourinary & hormones

    100%
    Progestin100%
    Megestrol Acetate100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Wu Zhang384Dongyun Yang355Francesca Battaglin280

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/heinz-lenz-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/heinz-josef-lenz-5a6001178

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/scientific-contributions/Heinz-Josef-Lenz-38617334

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/uscnorriscancercenter/p/CPBeVXIlxRv

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
  • Other

    blog.f1000.com/2014/11/20/clinical-challenges-in-colon-cancer-an-interview-with-heinz-josef-lenz

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog.f1000.com
  • Other

    oncologytube.com/heinz-josef-lenz-md-uscnorris-usc-keckmedusc-ascogi22-gi22-mcrc-rearch-pcm-075-with-folfiri-bev

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncologytube.com
5 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship in Biochemistry and Molecular Biology

    USC Norris Comprehensive Cancer Center

    1994
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu
  • Residency

    Hematology and Oncology, University Hospital (Universitätsklinik) Tübingen, Germany

    1991
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.sc-ctsi.org
  • M.D.

    Johannes-Gutenberg Universität, Mainz, Germany

    1985
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu
  • FACP - Fellow

    American College of Physicians

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ellisonmedicalinstitute.org

Editorial & leadership roles

journal and society appointments
  • Chair

    Translational Medicine Subcommittee, SWOG GI Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu
  • Member

    NCI Gastroesophageal Task Force and Clinical Trial Planning Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu
  • Member

    NCI Investigational Drug Steering Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu
2 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
10 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
1 more affiliation behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances
2 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.